214,99 €
Recombinant human interleukin-2 became available for clinical use in the mid 1980s. Recent years have seen an enormous amount of clinical research with this cytokine and interleukin-2 has now been registered for use in a number of European countries for the treatment of metastatic renal cell carcinoma. This book is...
Direkt bei Thalia AT bestellenMarke | Springer Netherlands |
EAN | 9780792321644 |
ISBN | 978-0-7923-2164-4 |